Literature DB >> 21225759

Management of transitional cell carcinoma of the lacrimal sac: a multidisciplinary approach to orbit sparing treatment.

Linda N Lee1, Andrew R Scott, Annie W Chan, Robert A Frankenthaler.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 21225759     DOI: 10.1002/lary.21625

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


× No keyword cloud information.
  5 in total

1.  Clinical analysis of 90 cases of malignant lacrimal sac tumor.

Authors:  Xinmao Song; Jie Wang; Shengzi Wang; Weifang Wang; Shuyi Wang; Wenjia Zhu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-29       Impact factor: 3.117

2.  Rare transitional cell carcinoma of the lacrimal sac.

Authors:  Hayley V Miller; John D Siddens
Journal:  Am J Ophthalmol Case Rep       Date:  2020-09-05

3.  Multidisciplinary management of lacrimal sac/nasolacrimal duct carcinomas.

Authors:  Tarek El-Sawy; Steven J Frank; Ehab Hanna; Matthew Sniegowski; Stephen Y Lai; Qasiem J Nasser; Jeffrey Myers; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2013 Nov-Dec       Impact factor: 1.746

4.  Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report.

Authors:  Ming-Hui Sun; Wei-Dong Yi; Ling Shen; Lu Zhou; Jian-Xun Lu
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534

5.  Comparison of Clinical Features and Treatment Outcome in Benign and Malignant Lacrimal Sac Tumors.

Authors:  Che-Yuan Kuo; Chieh-Chih Tsai; Shu-Ching Kao; Wen-Ming Hsu; Catherine Jui-Ling Liu
Journal:  Biomed Res Int       Date:  2020-01-31       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.